Pakistan and China signed nine pharma agreements worth over $440 million at a B2B conference in Islamabad, covering vaccines, biotech, drug manufacturing and technology transfer, with prospects for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results